banner
News center
Talented employees are the foundation of our company.

UC Makerspace jump

Aug 04, 2023

The University of Cincinnati’s 2023-24 academic year is about to begin, and the UC Ground Floor Makerspace is jump-starting the fall semester with the facility’s most popular hands-on programs, including woodshop, laser cutting, metalshop and benchtop CNC.

“Whether students need certifications for an upcoming project, want a head start this semester or are ready to try something new, we’ve built this opportunity for them,” said Lucy Weaver, Makerspace coordinator.

Programs include:

The UC Ground Floor Makerspace is a 12,000-square-foot prototyping and fabrication facility that empowers creative problem solvers through training, access to equipment and resources from ideation to creation.

Current UC students, faculty, staff and 1819 building partners qualify for zero-cost membership. Community members can purchase memberships for a monthly fee. Introductions and certifications are always free for members.

Featured image at top: 3D printing is one of the workshops being offered in the UC Ground Floor Makerspace Jumpstart this fall.

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

November 16, 2022

University of Cincinnati President Neville Pinto, UC Executive Vice President Ryan Hays, Ohio Lt. Gov. Jon Husted and entrepreneurs within the Cincinnati Innovation District today celebrated the economic impacts of the Ohio IP Promise — a statewide commercialization initiative launched in 2019 that streamlines the patent and licensing process, enabling inventors to own their intellectual property.

November 17, 2022

Researchers at colleges and universities across Ohio used to face a number of obstacles when it came to commercializing their ideas.

October 7, 2022

A University of Cincinnati Venture Lab-backed startup is developing a breast cancer treatment that may be more effective with fewer side effects thanks to RNA nanotechnology that is similar to what was used to produce COVID-19 vaccines.